__timestamp | AstraZeneca PLC, AZN | Eli Lilly and Company, LLY | GSK plc, GSK | Takeda Pharmaceutical Company Limited, TAK |
---|---|---|---|---|
Saturday, October 1, 2022 | 0.080396181 | 0.2653729217 | 0.1980748373 | 0.1086379019 |
Sunday, January 1, 2023 | 0.1657321445 | 0.1932327586 | 0.2143576464 | 0.0325616322 |
Saturday, April 1, 2023 | 0.1592501752 | 0.2121244932 | 0.2262468654 | 0.0844450028 |
Saturday, July 1, 2023 | 0.119561434 | -0.0060429958 | 0.1796980484 | -0.046045927 |
Sunday, October 1, 2023 | 0.0798403194 | 0.2341073834 | 0.0434674615 | 0.0951415875 |
Monday, January 1, 2024 | 0.1718589794 | 0.2558052007 | 0.1420616596 | -0.0028719089 |
Monday, April 1, 2024 | 0.1489411037 | 0.2625013271 | 0.148782344 | 0.0788483348 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding the financial health of leading companies is crucial. This analysis delves into the net income margins of four pharmaceutical giants—GlaxoSmithKline (GSK), AstraZeneca, Takeda, and Eli Lilly—over the past eight quarters, providing a comprehensive view of their profitability trends.
This comparative analysis highlights the financial resilience and challenges faced by these pharmaceutical leaders. Eli Lilly's robust recovery and GSK's fluctuating margins underscore the dynamic nature of the industry. Investors and stakeholders can leverage these insights to make informed decisions in this competitive landscape.
5 Year Trend in Average Market Capitalization for AbbVie
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
Average Market Capitalization of Abbvie Annually
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Pharma Companies
5 Year Trend in Average Market Capitalization for AbbVie
5 Year Trend in Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Number of Employees for Top 10 Healthcare Companies
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters